JP2024069459A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024069459A5 JP2024069459A5 JP2024039768A JP2024039768A JP2024069459A5 JP 2024069459 A5 JP2024069459 A5 JP 2024069459A5 JP 2024039768 A JP2024039768 A JP 2024039768A JP 2024039768 A JP2024039768 A JP 2024039768A JP 2024069459 A5 JP2024069459 A5 JP 2024069459A5
- Authority
- JP
- Japan
- Prior art keywords
- vial
- asmd
- lyophilized composition
- moisture
- human patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862676525P | 2018-05-25 | 2018-05-25 | |
| US62/676,525 | 2018-05-25 | ||
| PCT/US2019/033983 WO2019227029A1 (en) | 2018-05-25 | 2019-05-24 | Pharmaceutical compositions for treating acid sphingomyelinase deficiency |
| JP2020565415A JP7497300B2 (ja) | 2018-05-25 | 2019-05-24 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565415A Division JP7497300B2 (ja) | 2018-05-25 | 2019-05-24 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024069459A JP2024069459A (ja) | 2024-05-21 |
| JP2024069459A5 true JP2024069459A5 (https=) | 2025-04-04 |
| JP7832245B2 JP7832245B2 (ja) | 2026-03-17 |
Family
ID=66912954
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565415A Active JP7497300B2 (ja) | 2018-05-25 | 2019-05-24 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
| JP2024039768A Active JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565415A Active JP7497300B2 (ja) | 2018-05-25 | 2019-05-24 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210145941A1 (https=) |
| EP (1) | EP3802805A1 (https=) |
| JP (2) | JP7497300B2 (https=) |
| KR (1) | KR102852946B1 (https=) |
| CN (1) | CN112424347A (https=) |
| AU (2) | AU2019275109C1 (https=) |
| BR (1) | BR112020023829A2 (https=) |
| CA (1) | CA3101688A1 (https=) |
| CO (1) | CO2020014399A2 (https=) |
| IL (1) | IL278964A (https=) |
| MX (2) | MX2020012700A (https=) |
| PY (1) | PY1939780A (https=) |
| SG (1) | SG11202011488WA (https=) |
| UY (1) | UY38238A (https=) |
| WO (1) | WO2019227029A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4284442A4 (en) * | 2021-02-01 | 2025-04-23 | The Trustees of The University of Pennsylvania | COMPOSITIONS AND METHODS FOR TREATING NIEMANN PICK DISEASE TYPE A |
| TW202403043A (zh) | 2022-03-18 | 2024-01-16 | 美商健臻公司 | 重組人類酸性鞘磷脂酶醫藥組合物及方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5773278A (en) | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
| EP1450847B1 (en) | 2001-11-13 | 2010-09-29 | Genentech, Inc. | APO2 ligand/ TRAIL formulations and uses thereof |
| EP1638595B1 (en) | 2003-06-20 | 2013-03-20 | Ares Trading S.A. | Freeze-dried fsh / lh formulations |
| CN101214249A (zh) * | 2003-11-25 | 2008-07-09 | 纽约大学西奈山医学院 | 尼曼-皮克病的基于陪伴分子的治疗 |
| AR059089A1 (es) * | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal |
| HRP20120994T1 (hr) | 2006-02-07 | 2012-12-31 | Shire Human Genetic Therapies, Inc. | Stabilizirana smjesa glukocerebrozidaze |
| AU2007226582B2 (en) * | 2006-03-13 | 2012-07-05 | Revvity Health Sciences, Inc. | Substrates and internal standards for mass spectroscopy detection |
| JP2009530284A (ja) * | 2006-03-13 | 2009-08-27 | エンサイシブ・ファーマシューティカルズ・インコーポレイテッド | 拡張期心不全を治療するための方法と組成物 |
| JP2012530721A (ja) | 2009-06-18 | 2012-12-06 | ワイス・エルエルシー | 小モジュール免疫薬のための凍結乾燥製剤 |
| SI3998078T1 (sl) | 2009-08-28 | 2026-02-27 | Genzyme Corporation | Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze |
| JP6073783B2 (ja) * | 2010-06-25 | 2017-02-01 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | ヘパランｎ−スルファターゼのｃｎｓ送達のための方法および組成物 |
| PL3241547T3 (pl) | 2011-03-31 | 2021-02-08 | Medy-Tox Inc. | Liofilizowany preparat toksyny botulinowej |
| JP6480154B2 (ja) | 2014-11-06 | 2019-03-06 | 持田製薬株式会社 | エタネルセプトの凍結乾燥製剤 |
| FI126979B (en) * | 2016-02-29 | 2017-09-15 | Faron Pharmaceuticals Oy | Lyophilized pharmaceutical formulation and its use |
| KR20250025051A (ko) * | 2017-08-24 | 2025-02-20 | 사노피 | 산성 스핑고미엘린분해효소 결핍증 환자에서의 비정상적 골병태의 치료 |
-
2019
- 2019-05-23 PY PY201901939780A patent/PY1939780A/es unknown
- 2019-05-23 UY UY0001038238A patent/UY38238A/es not_active Application Discontinuation
- 2019-05-24 CN CN201980048133.7A patent/CN112424347A/zh active Pending
- 2019-05-24 AU AU2019275109A patent/AU2019275109C1/en active Active
- 2019-05-24 SG SG11202011488WA patent/SG11202011488WA/en unknown
- 2019-05-24 EP EP19731419.8A patent/EP3802805A1/en active Pending
- 2019-05-24 WO PCT/US2019/033983 patent/WO2019227029A1/en not_active Ceased
- 2019-05-24 MX MX2020012700A patent/MX2020012700A/es unknown
- 2019-05-24 JP JP2020565415A patent/JP7497300B2/ja active Active
- 2019-05-24 CA CA3101688A patent/CA3101688A1/en active Pending
- 2019-05-24 KR KR1020207037328A patent/KR102852946B1/ko active Active
- 2019-05-24 BR BR112020023829-5A patent/BR112020023829A2/pt unknown
-
2020
- 2020-11-20 CO CONC2020/0014399A patent/CO2020014399A2/es unknown
- 2020-11-25 MX MX2025002733A patent/MX2025002733A/es unknown
- 2020-11-25 IL IL278964A patent/IL278964A/en unknown
- 2020-11-25 US US17/104,593 patent/US20210145941A1/en active Pending
-
2024
- 2024-03-14 JP JP2024039768A patent/JP7832245B2/ja active Active
-
2025
- 2025-07-17 AU AU2025205577A patent/AU2025205577A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024069459A5 (https=) | ||
| Mason et al. | A systematic review of foot ulcer in patients with type 2 diabetes mellitus. II: treatment | |
| US4289750A (en) | Therapy of conditions which may be associated with altered renal function and dosage forms therefor | |
| Greco et al. | Hydrofluoric acid-induced hypocalcemia | |
| ES2750553T3 (es) | Prevención y tratamiento de las infecciones microbianas | |
| Ropper et al. | Limited relapse in Guillain-Barré syndrome after plasma exchange | |
| CA2288143A1 (en) | Activated protein c formulations | |
| Kumar et al. | Bisphosphonate-related osteonecrosis of the jaws: a report of three cases demonstrating variability in outcomes and morbidity | |
| US20090182055A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
| Groote | Rhinocerebral phycomycosis | |
| SE536581C2 (sv) | Ett kit för behandling av sår eller liknande och ett preparat och metoder därav | |
| JPH06503319A (ja) | 細胞増殖マトリックス及びその用法 | |
| JPH0222223A (ja) | 医薬組成物 | |
| JP2021525083A5 (https=) | ||
| Paterson et al. | Severe disseminated staphylococcal disease associated with osteitis and septic arthritis | |
| CN103007258A (zh) | 含鱼丝氨酸蛋白酶和抗菌化合物的医用组合物及其用途 | |
| Nabi et al. | The effectiveness of ozone therapy in chronic osteomyelitis: A randomized controlled clinical trial | |
| ES2312421T3 (es) | Composicion farmaceutica en gel. | |
| WO2004103399A1 (fr) | Utilisation d'ulinastatine pour traiter le syndrome respiratoire aigu et composition pharmaceutique contenant ulinastatine | |
| EP0074426A1 (en) | Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions | |
| ES2962272T3 (es) | Agentes para su uso en estados inflamatorios de las mucosas | |
| TWI773927B (zh) | 促進及治療慢性傷口癒合之組合物及方法 | |
| ES2331461T3 (es) | Composiciones para el tratamiento de la hemorragia con un factor activo viia y fibrinogeno. | |
| Bobobekov | OPTIMIZATION OF DIAGNOSTIC AND TREATMENT METHODS ACUTE ABSCESSES AND GANGRENG OF LUNGS IN PATIENTS WITH DIABETES | |
| RU2077886C1 (ru) | Способ лечения инкурабельных больных |